Athira Pharma
ATHA
ATHA
69 hedge funds and large institutions have $484M invested in Athira Pharma in 2021 Q1 according to their latest regulatory filings, with 11 funds opening new positions, 27 increasing their positions, 15 reducing their positions, and 12 closing their positions.
New
Increased
Maintained
Reduced
Closed
more repeat investments, than reductions
Existing positions increased: | Existing positions reduced:
more ownership
Funds ownership: →
less first-time investments, than exits
New positions opened: | Existing positions closed:
less funds holding
Funds holding: →
34% less capital invested
Capital invested by funds: $734M → $484M (-$249M)
100% less funds holding in top 10
Funds holding in top 10: 3 → 0 (-3)
Holders
69
Holding in Top 10
–
Calls
–
Puts
–
Top Buyers
| 1 | +$27.1M | |
| 2 | +$14.9M | |
| 3 | +$11.7M | |
| 4 |
Point72 Asset Management
Stamford,
Connecticut
|
+$8.15M |
| 5 |
PFO
Pathstone Family Office
Englewood,
New Jersey
|
+$7.68M |
Top Sellers
| 1 | -$3.42M | |
| 2 | -$3.03M | |
| 3 | -$1.85M | |
| 4 |
Bank of America
Charlotte,
North Carolina
|
-$1.78M |
| 5 |
CCM
CAAS Capital Management
New York
|
-$1.71M |